Your browser doesn't support javascript.
loading
Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancer.
Ahn, Beung-Chul; So, Jea-Woo; Synn, Chun-Bong; Kim, Tae Hyung; Kim, Jae Hwan; Byeon, Yeongseon; Kim, Young Seob; Heo, Seong Gu; Yang, San-Duk; Yun, Mi Ran; Lim, Sangbin; Choi, Su-Jin; Lee, Wongeun; Kim, Dong Kwon; Lee, Eun Ji; Lee, Seul; Lee, Doo-Jae; Kim, Chang Gon; Lim, Sun Min; Hong, Min Hee; Cho, Byoung Chul; Pyo, Kyoung-Ho; Kim, Hye Ryun.
Afiliação
  • Ahn BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • So JW; TheragenBio, Seongnam, Republic of Korea.
  • Synn CB; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim TH; TheragenBio, Seongnam, Republic of Korea.
  • Kim JH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Byeon Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim YS; Department of Research Support, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Heo SG; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yang SD; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yun MR; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Republic of Korea.
  • Lim S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Choi SJ; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Lee W; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-City, Republic of Korea.
  • Kim DK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Lee EJ; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Lee S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Lee DJ; Wide River Institute of Immunology (WRII) Seoul National University, Hongcheon-gun, Gangwon-do 250-812, Republic of Korea.
  • Kim CG; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Lim SM; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Hong MH; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Pyo KH; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: pkhpsh@yuhs.ac.
  • Kim HR; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: nobelg@yuhs.ac.
Eur J Cancer ; 153: 179-189, 2021 08.
Article em En | MEDLINE | ID: mdl-34182269

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Aprendizado de Máquina / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Aprendizado de Máquina / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article